Inactive Instrument

All News Forty Seven, Inc.

Equities

US34983P1049

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

FORTY SEVEN, INC. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	20-04-07	AQ
Forty Seven, Inc.(NasdaqGS:FTSV) dropped from S&P TMI Index	20-04-07	CI
Forty Seven, Inc.(NasdaqGS:FTSV) dropped from S&P Global BMI Index	20-04-07	CI
Gilead Sciences, Inc. completed the acquisition of Forty Seven, Inc..	20-04-05	CI
FORTY SEVEN : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	20-03-20	AQ
Forty Seven, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights	20-03-20	GL
Forty Seven, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2019	20-03-20	CI
Forty Seven and Rocket Pharmaceuticals Announce Research Collaboration for Fanconi Anemia	20-03-11	GL
Forty Seven and Rocket Pharmaceuticals Announce Research Collaboration for Fanconi Anemia	20-03-11	CI
Certain Common Stock of Forty Seven, Inc. are subject to a Lock-Up Agreement Ending on 11-MAR-2020.	20-03-10	CI
Certain Stock Options of Forty Seven, Inc. are subject to a Lock-Up Agreement Ending on 11-MAR-2020.	20-03-10	CI
Forty Seven : Thermo Fisher agrees to buy genetic tester Qiagen in $11.5 billion deal	20-03-03	RE
Forty Seven : Gilead buys Forty Seven for $4.9 billion to bolster cancer drug pipeline	20-03-02	RE
Forty Seven : Gilead to Acquire Forty Seven for $4.9 Billion	20-03-02	BU
FORTY SEVEN, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	20-03-02	AQ
Gilead Sciences : buying Forty Seven for $4.9 billion	20-03-02	AQ
Gilead Sciences, Inc. entered into a definitive agreement to acquire Forty Seven, Inc. for $4.6 billion.	20-03-01	CI
VMware : Beyond Meat, Dell fall; 3M, Forty Seven rise	20-02-28	AQ
Gilead Sciences Reportedly Approaches Forty Seven with a Takeover Offer	20-02-28	CI
Forty Seven to Present at Upcoming Investor Conferences in March	20-02-25	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Forty Seven, Inc.

Equities

US34983P1049

All News

Filters